-
Je něco špatně v tomto záznamu ?
Does the change in Liver Frailty Index over the first week of hospitalisation predict mortality in patients with acute-on-chronic liver failure? A prospective cohort study from a Slovak liver centre
Ľ. Skladaný, D. Líška, K. Mesiková, D. Havaj, S. Adamcová-Selčanová, K. Šulejová, D. Žilinčanová, P. Kohout
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Nursing & Allied Health Database (ProQuest)
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
Family Health Database (ProQuest)
od 2011-01-01
Psychology Database (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
- MeSH
- akutní zhoršení chronického selhání jater * mortalita MeSH
- dospělí MeSH
- hospitalizace * MeSH
- játra * patofyziologie MeSH
- křehkost * MeSH
- lidé středního věku MeSH
- lidé MeSH
- prognóza MeSH
- prospektivní studie MeSH
- senioři MeSH
- stupeň závažnosti nemoci MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Slovenská republika MeSH
OBJECTIVE: Hospital admissions for advanced chronic liver disease (ACLD) are associated with increased mortality, disability, a decline in quality of life and significant economic costs. Being admitted to the hospital usually indicates a triggering event that disrupted a previously stable condition, leading to decompensation or complications of ACLD. The most acute and severe manifestation of this imbalance is acute-on-chronic liver failure (ACLF), a syndrome representing a critical juncture. Reliable prognostic stratification of patients admitted with ACLF could facilitate the systematic delivery of tailored care, ranging from palliative care to intensive interventions like extracorporeal liver support devices and prioritised liver transplantation. Disease-specific prognostic tools, such as the Model for End-Stage Liver Disease score, are effective but have limitations, particularly in reflecting a patient's potential for recovery. The concept of the body's functional reserve in the context of ACLD/ACLF is gaining attention, with the Liver Frailty Index (LFI) potentially emerging as a recommended diagnostic tool. METHODS: Patients were selected from our cirrhosis registry (RH7). The LFI serves as an indicator of the patient's prognosis. The LFI measurement takes place at two time intervals: on the patient's admission and after 7 days of hospitalisation. RESULTS: Our RH7 registry included 154 patients (15.1%) who were diagnosed with ACLF. The primary cause of the underlying ACLD was alcohol-associated liver disease in the majority (79.8%) of cases. The mean value of LFI at admission was 4.50 (± 0.94). When patients with liver cirrhosis were categorised into three subgroups based on the LFI on day 7, survival exhibited a statistically significant decrease (p≤0.05) across all three ACLF grades. This decline in survival was observed from the 'improved LFI' cohort, through the 'stable LFI' group, to the 'worsened LFI' group. CONCLUSION: The impact of day 7 LFI on the survival of patients with ACLF is notable. Nevertheless, it does not markedly enhance the predictive capability of the LFI assessed on admission. Consequently, the initial LFI on day 1 continues to be the most valuable and commonly used instrument for promptly recognising individuals with ACLF.
F D Roosevelt University Hospital of Banská Bystrica Banská Bystrica Slovakia
Faculty of Sport Science and Health Matej Bel University Banska Bystrica Slovakia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015631
- 003
- CZ-PrNML
- 005
- 20250731091132.0
- 007
- ta
- 008
- 250708s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/bmjopen-2025-100171 $2 doi
- 035 __
- $a (PubMed)40441763
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Skladaný, Ľubomír $u Department of Hepatology, Gastroenterology, and Transplantation, 2nd Department of Medicine, Slovak Medical University Faculty of Medicine, F. D. Roosevelt Hospital, Banska Bystrica, Slovakia
- 245 10
- $a Does the change in Liver Frailty Index over the first week of hospitalisation predict mortality in patients with acute-on-chronic liver failure? A prospective cohort study from a Slovak liver centre / $c Ľ. Skladaný, D. Líška, K. Mesiková, D. Havaj, S. Adamcová-Selčanová, K. Šulejová, D. Žilinčanová, P. Kohout
- 520 9_
- $a OBJECTIVE: Hospital admissions for advanced chronic liver disease (ACLD) are associated with increased mortality, disability, a decline in quality of life and significant economic costs. Being admitted to the hospital usually indicates a triggering event that disrupted a previously stable condition, leading to decompensation or complications of ACLD. The most acute and severe manifestation of this imbalance is acute-on-chronic liver failure (ACLF), a syndrome representing a critical juncture. Reliable prognostic stratification of patients admitted with ACLF could facilitate the systematic delivery of tailored care, ranging from palliative care to intensive interventions like extracorporeal liver support devices and prioritised liver transplantation. Disease-specific prognostic tools, such as the Model for End-Stage Liver Disease score, are effective but have limitations, particularly in reflecting a patient's potential for recovery. The concept of the body's functional reserve in the context of ACLD/ACLF is gaining attention, with the Liver Frailty Index (LFI) potentially emerging as a recommended diagnostic tool. METHODS: Patients were selected from our cirrhosis registry (RH7). The LFI serves as an indicator of the patient's prognosis. The LFI measurement takes place at two time intervals: on the patient's admission and after 7 days of hospitalisation. RESULTS: Our RH7 registry included 154 patients (15.1%) who were diagnosed with ACLF. The primary cause of the underlying ACLD was alcohol-associated liver disease in the majority (79.8%) of cases. The mean value of LFI at admission was 4.50 (± 0.94). When patients with liver cirrhosis were categorised into three subgroups based on the LFI on day 7, survival exhibited a statistically significant decrease (p≤0.05) across all three ACLF grades. This decline in survival was observed from the 'improved LFI' cohort, through the 'stable LFI' group, to the 'worsened LFI' group. CONCLUSION: The impact of day 7 LFI on the survival of patients with ACLF is notable. Nevertheless, it does not markedly enhance the predictive capability of the LFI assessed on admission. Consequently, the initial LFI on day 1 continues to be the most valuable and commonly used instrument for promptly recognising individuals with ACLF.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a akutní zhoršení chronického selhání jater $x mortalita $7 D065290
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a hospitalizace $7 D006760
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a křehkost $7 D000073496
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a játra $x patofyziologie $7 D008099
- 651 _2
- $a Slovenská republika $x epidemiologie $7 D018154
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Líška, Dávid $u Faculty of Sport Science and Health, Matej Bel University, Banska Bystrica, Slovakia david.liska27@gmail.com $1 https://orcid.org/0000000257001341
- 700 1_
- $a Mesiková, Klaudia $u F.D. Roosevelt University Hospital of Banská Bystrica, Banská Bystrica, Slovakia
- 700 1_
- $a Havaj, Daniel $u Department of Hepatology, Gastroenterology, and Transplantation, 2nd Department of Medicine, Slovak Medical University Faculty of Medicine, F. D. Roosevelt Hospital, Banska Bystrica, Slovakia
- 700 1_
- $a Adamcová-Selčanová, Sveltana $u Department of Hepatology, Gastroenterology, and Transplantation, 2nd Department of Medicine, Slovak Medical University Faculty of Medicine, F. D. Roosevelt Hospital, Banska Bystrica, Slovakia
- 700 1_
- $a Šulejová, Karolína $u Department of Hepatology, Gastroenterology, and Transplantation, 2nd Department of Medicine, Slovak Medical University Faculty of Medicine, F. D. Roosevelt Hospital, Banska Bystrica, Slovakia
- 700 1_
- $a Žilinčanová, Daniela $u Department of Hepatology, Gastroenterology, and Transplantation, 2nd Department of Medicine, Slovak Medical University Faculty of Medicine, F. D. Roosevelt Hospital, Banska Bystrica, Slovakia
- 700 1_
- $a Kohout, Pavel $u Department of Internal Medicine, Third Faculty of Medicine, Charles University Prague and Teaching Thomayer Hospital, Prague, Czech Republic
- 773 0_
- $w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 15, č. 5 (2025), s. e100171
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40441763 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091127 $b ABA008
- 999 __
- $a ok $b bmc $g 2366470 $s 1252756
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 15 $c 5 $d e100171 $e 20250528 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
- LZP __
- $a Pubmed-20250708